Across TCGA pan-cancer cohorts, SLC9B1P2 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of SLC9B1P2’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where SLC9B1P2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SLC9B1P2 is over-expressed in tumor, although a few such as KIRP and KICH show the opposite, repressed pattern.

HNSC, KIRP, and KICH are the cancer types where SLC9B1P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SLC9B1P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	IV	+0.048	.025	5	view →
KIRP	All	All	−0.011	.032	3	view →
KICH	All	II,III,IV	−0.014	.034	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: SLC9B1P2 RNA expression & survival · all SLC9B1P2 data types